Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bertz

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|November 4, 2008
Allogeneic hematopoietic cell transplantation for t-AML following liver transplantation from the same haploidentical donorR Zeiser, A Zerweck, H Bertz, et al.
Annals of Hematology|December 2, 2022
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantationK Enger, X Tonnar, E Kotter, et al.
Transplantation|August 13, 1998
Sinus venous thrombosis: an unusual cause for neurologic symptoms after bone marrow transplantation under immunosuppressionH Bertz, J Laubenberger, G Steinfurth, et al.
Bone Marrow Transplantation|June 1, 1997
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicityH Bertz, K Potthoff, R Mertelsmann, et al.
Journal of the American Chemical Society|February 3, 2005
Remarkable effect of silyl groups on asymmetric induction in a conjugate addition reaction with O-methylnorephedrine-based N-silylamidocupratesSteven H Bertz, Craig A Ogle, Abhinav Rastogi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimensH Bertz, G Illerhaus, H Veelken, et al.
British Journal of Haematology|November 25, 1998
Successful adoptive immunotherapy for relapse of AML 9 years after T-cell-depleted BMTH Bertz, R Kunzman, D Bunjes, et al.
British Journal of Haematology|August 6, 2000
Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantationR Wäsch, H Bertz, R Kunzmann, et al.
Bone Marrow Transplantation|August 30, 2008
Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALLA Spyridonidis, H Bertz, M Waterhouse, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 31, 2001
Extent and time course of morphological changes of bone marrow induced by granulocyte-colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donorsC Altehoefer, H Bertz, N A Ghanem, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|November 4, 2008
Allogeneic hematopoietic cell transplantation for t-AML following liver transplantation from the same haploidentical donorR Zeiser, A Zerweck, H Bertz, et al.
Annals of Hematology|December 2, 2022
Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantationK Enger, X Tonnar, E Kotter, et al.
Transplantation|August 13, 1998
Sinus venous thrombosis: an unusual cause for neurologic symptoms after bone marrow transplantation under immunosuppressionH Bertz, J Laubenberger, G Steinfurth, et al.
Bone Marrow Transplantation|June 1, 1997
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicityH Bertz, K Potthoff, R Mertelsmann, et al.
Journal of the American Chemical Society|February 3, 2005
Remarkable effect of silyl groups on asymmetric induction in a conjugate addition reaction with O-methylnorephedrine-based N-silylamidocupratesSteven H Bertz, Craig A Ogle, Abhinav Rastogi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimensH Bertz, G Illerhaus, H Veelken, et al.
British Journal of Haematology|November 25, 1998
Successful adoptive immunotherapy for relapse of AML 9 years after T-cell-depleted BMTH Bertz, R Kunzman, D Bunjes, et al.
British Journal of Haematology|August 6, 2000
Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantationR Wäsch, H Bertz, R Kunzmann, et al.
Bone Marrow Transplantation|August 30, 2008
Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALLA Spyridonidis, H Bertz, M Waterhouse, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 31, 2001
Extent and time course of morphological changes of bone marrow induced by granulocyte-colony stimulating factor as assessed by magnetic resonance imaging of healthy blood stem cell donorsC Altehoefer, H Bertz, N A Ghanem, et al.
Pageof 12